Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis
M Lerch, C Mainetti, B Terziroli Beretta-Piccoli… - Clinical reviews in …, 2018 - Springer
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are considered a
delayed-type hypersensitivity reaction to drugs. They represent true medical emergencies …
delayed-type hypersensitivity reaction to drugs. They represent true medical emergencies …
An updated review of the molecular mechanisms in drug hypersensitivity
Drug hypersensitivity may manifest ranging from milder skin reactions (eg, maculopapular
exanthema and urticaria) to severe systemic reactions, such as anaphylaxis, drug reactions …
exanthema and urticaria) to severe systemic reactions, such as anaphylaxis, drug reactions …
Drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis
N Hama, R Abe, A Gibson, EJ Phillips - The Journal of Allergy and Clinical …, 2022 - Elsevier
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic
symptoms (DIHS/DRESS) is one example of a severe delayed T-cell–mediated adverse …
symptoms (DIHS/DRESS) is one example of a severe delayed T-cell–mediated adverse …
[HTML][HTML] Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis
A Hasegawa, R Abe - F1000Research, 2020 - ncbi.nlm.nih.gov
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening
diseases characterized by detachment of the epidermis and mucous membrane. SJS/TEN …
diseases characterized by detachment of the epidermis and mucous membrane. SJS/TEN …
The role of pharmacogenomics in adverse drug reactions
R Cacabelos, N Cacabelos, JC Carril - Expert Review of Clinical …, 2019 - Taylor & Francis
ABSTRACT Introduction: Adverse drug reactions (ADRs) are a major health concern
worldwide. There are multiple causes of ADRs, some of which are preventable …
worldwide. There are multiple causes of ADRs, some of which are preventable …
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and …
BM Wei, LP Fox, BH Kaffenberger, AM Korman… - Journal of the American …, 2024 - Elsevier
Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with
eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction …
eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction …
Drug reaction with eosinophilia and systemic symptoms (DReSS)/Drug-Induced hypersensitivity syndrome (DiHS)—readdressing the DReSS
H Stirton, NH Shear, RP Dodiuk-Gad - Biomedicines, 2022 - mdpi.com
Drug reaction with eosinophilia and systemic symptoms (DReSS), also known as drug-
induced hypersensitivity syndrome (DiHS), is a severe, systemic, T cell mediated drug …
induced hypersensitivity syndrome (DiHS), is a severe, systemic, T cell mediated drug …
[HTML][HTML] Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity
Individuals differ substantially in their response to pharmacological treatment. Personalized
medicine aspires to embrace these inter-individual differences and customize therapy by …
medicine aspires to embrace these inter-individual differences and customize therapy by …
An updated review of genetic associations with severe adverse drug reactions: Translation and implementation of pharmacogenomic testing in clinical practice
CW Wang, IAC Preclaro, WH Lin… - Frontiers in …, 2022 - frontiersin.org
Adverse drug reactions (ADR) remain the major problems in healthcare. Most severe ADR
are unpredictable, dose-independent and termed as type B idiosyncratic reactions. Recent …
are unpredictable, dose-independent and termed as type B idiosyncratic reactions. Recent …
Drug reaction with eosinophilia and systemic symptoms (DRESS): focus on the pathophysiological and diagnostic role of viruses
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a heterogeneous,
multiorgan and potentially life-threatening drug-hypersensitivity reaction (DHR) that occurs …
multiorgan and potentially life-threatening drug-hypersensitivity reaction (DHR) that occurs …